Anticancer drug-induced kidney disorders.

作者: Polly E. Kintzel

DOI: 10.2165/00002018-200124010-00003

关键词:

摘要: … ), 125 I-iothalamate, 131 I-diatrizoate] and clearance of radiocontrast agents (iothalamate, diatrizoate), although these tests are generally reserved for use in clinical research.[14–16,21] …

参考文章(148)
Rizel S, Ben-Baruch G, Brenner H, Menczer J, Acute renal failure associated with intraperitoneal cisplatin chemotherapy with systemic thiosulfate protection in ovarian cancer patients. European Journal of Gynaecological Oncology. ,vol. 12, pp. 403- ,(1991)
EJ Lee, DA Van Echo, MJ Egorin, MS Nayar, P Shulman, CA Schiffer, Diaziquone given as a continuous infusion is an active agent for relapsed adult acute nonlymphocytic leukemia. Blood. ,vol. 67, pp. 182- 187 ,(1986) , 10.1182/BLOOD.V67.1.182.182
M. G. Coulthard, A. W. Craft, R. Skinner, L. Price, A. D. J. Pearson, The influence of age on nephrotoxicity following chemotherapy in children. The British journal of cancer. Supplement. ,vol. 18, ,(1992)
Weinblatt Me, Toxicity of low dose methotrexate in rheumatoid arthritis. The Journal of Rheumatology Supplement. pp. 35- 39 ,(1985)
S Laurin, L Giroux, J Gruber, P R Band, J Jolivet, P Bettez, Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome. Cancer treatment reports. ,vol. 67, pp. 429- 434 ,(1983)
Bruce A. Molitoris, Timothy A. Sutton, Mechanisms of cellular injury in ischemic acute renal failure. Seminars in Nephrology. ,vol. 18, pp. 490- 497 ,(1998)
Pratt Cb, Goren Mp, Wright Rk, Horowitz Me, Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna. Cancer treatment reports. ,vol. 71, pp. 127- 130 ,(1987)
Erwin K. Kastrup, James R. Boyd, Sally Gifford, Drug facts and comparisons Facts and Comparisons Division, J.B. Lippincott. ,(1977)
Edward H. Kovnar, Marc E. Horowitz, Charles B. Pratt, Richard K. Dodge, Reba K. Wright, Mary J. Viar, Marshall P. Goren, Potentiation of Ifosfamide Neurotoxicity, Hematotoxicity, and Tubular Nephrotoxicity by Prior cis-Diamminedichloroplatinum(II) Therapy Cancer Research. ,vol. 47, pp. 1457- 1460 ,(1987)